PAUL HARTMANN AG (PHH2) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

High Management Efficiency with a high ROCE of 8,255.25%

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 82.55

Poor long term growth as Operating profit has grown by an annual rate 5.71% of over the last 5 years

With ROE of 4.49%, it has a Expensive valuation with a 0.73 Price to Book Value

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 779 Million ()

P/E

16.00

Industry P/E

Dividend Yield

0.11%

Debt Equity

0.34

Return on Equity

4.49%

Price to Book

0.69

Revenue and Profits:

Net Sales:

444 Million

(Quarterly Results - Mar 2013)

Net Profit:

14 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-29.68%

6 Months

-34.7%

1 Year

-34.2%

2 Years

-45.27%

3 Years

-45.27%

4 Years

-45.27%

5 Years

-45.27%

PAUL HARTMANN AG for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

6.41%

EBIT Growth (5y)

5.71%

EBIT to Interest (avg)

82.55

Debt to EBITDA (avg)

Net Debt to Equity (avg)

0.04

Sales to Capital Employed (avg)

1.43

Tax Ratio

Dividend Payout Ratio

26.20%

Pledged Shares

Institutional Holding

ROCE (avg)

8,255.25%

ROE (avg)

4,069.54%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.73

EV to EBIT

21.08

EV to EBITDA

21.08

EV to Capital Employed

0.80

EV to Sales

0.68

PEG Ratio

Dividend Yield

0.11%

ROCE (Latest)

3.78%

ROE (Latest)

4.49%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'13 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2013 is 1.67% vs 4.98% in Mar 2012",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2013 is -25.65% vs 0.53% in Mar 2012",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'13",
        "Mar'12",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "443.80",
          "val2": "436.50",
          "chgp": "1.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "29.00",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.20",
          "val2": "19.10",
          "chgp": "-25.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "66.40%",
          "chgp": "-6.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.32% vs 1.80% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 247.71% vs -17.22% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,407.90",
          "val2": "2,353.30",
          "chgp": "2.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "218.10",
          "val2": "134.00",
          "chgp": "62.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.40",
          "val2": "14.20",
          "chgp": "22.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.20",
          "val2": "4.50",
          "chgp": "-28.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "113.70",
          "val2": "32.70",
          "chgp": "247.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.50%",
          "val2": "13.60%",
          "chgp": "3.39%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'13 - YoY

Mar'13

Mar'12

Change(%)

Net Sales

443.80

436.50

1.67%

Operating Profit (PBDIT) excl Other Income

0.00

29.00

-100.00%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

14.20

19.10

-25.65%

Operating Profit Margin (Excl OI)

0.00%

66.40%

-6.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2013 is 1.67% vs 4.98% in Mar 2012

Consolidated Net Profit

YoY Growth in quarter ended Mar 2013 is -25.65% vs 0.53% in Mar 2012

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,407.90

2,353.30

2.32%

Operating Profit (PBDIT) excl Other Income

218.10

134.00

62.76%

Interest

17.40

14.20

22.54%

Exceptional Items

3.20

4.50

-28.89%

Consolidate Net Profit

113.70

32.70

247.71%

Operating Profit Margin (Excl OI)

47.50%

13.60%

3.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 2.32% vs 1.80% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 247.71% vs -17.22% in Dec 2023

All Annual Results

Company CV

About PAUL HARTMANN AG

PAUL HARTMANN AG

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available